Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Bouchet

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Therapie|February 1, 2022
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitorsStéphane Bouchet, Mathieu Molimard
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapeutic Drug Monitoring|September 22, 2005
Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimesMarta Concheiro, Marion Villain, Stéphane Bouchet, et al.
Therapie|May 26, 2022
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)Florian Lemaitre, Matthieu Grégoire, Caroline Monchaud, et al.
Therapeutic Drug Monitoring|December 21, 2020
A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic FibrosisJean-Baptiste Woillard, Stéphane Bouchet, Michael Fayon, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 9, 2017
High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MSCamille Merienne, Marine Rousset, Dominique Ducint, et al.
Therapeutic Drug Monitoring|April 14, 2010
A method to measure deferasirox in plasma using HPLC coupled with MS/MS detection and its potential applicationEmmanuelle Chauzit, Stéphane Bouchet, Marguerite Micheau, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Annals of Clinical Biochemistry|October 16, 2016
Late diagnosis of primary hyperoxaluria type IIIEmmanuel Richard, Jean-Marc Blouin, Jérome Harambat, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Therapie|February 1, 2022
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitorsStéphane Bouchet, Mathieu Molimard
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapeutic Drug Monitoring|September 22, 2005
Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimesMarta Concheiro, Marion Villain, Stéphane Bouchet, et al.
Therapie|May 26, 2022
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)Florian Lemaitre, Matthieu Grégoire, Caroline Monchaud, et al.
Therapeutic Drug Monitoring|December 21, 2020
A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic FibrosisJean-Baptiste Woillard, Stéphane Bouchet, Michael Fayon, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 9, 2017
High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MSCamille Merienne, Marine Rousset, Dominique Ducint, et al.
Therapeutic Drug Monitoring|April 14, 2010
A method to measure deferasirox in plasma using HPLC coupled with MS/MS detection and its potential applicationEmmanuelle Chauzit, Stéphane Bouchet, Marguerite Micheau, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Annals of Clinical Biochemistry|October 16, 2016
Late diagnosis of primary hyperoxaluria type IIIEmmanuel Richard, Jean-Marc Blouin, Jérome Harambat, et al.
Pageof 4